| circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity B Li, L Zhu, C Lu, C Wang, H Wang, H Jin, X Ma, Z Cheng, C Yu, S Wang, ... Nature communications 12 (1), 295, 2021 | 422 | 2021 |
| Evolving therapeutic landscape of advanced hepatocellular carcinoma C Yang, H Zhang, L Zhang, AX Zhu, R Bernards, W Qin, C Wang Nature reviews Gastroenterology & hepatology 20 (4), 203-222, 2023 | 391 | 2023 |
| Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology C Yang, X Huang, Y Li, J Chen, Y Lv, S Dai Briefings in bioinformatics 22 (3), bbaa164, 2021 | 214 | 2021 |
| Metabolism‐associated molecular classification of hepatocellular carcinoma C Yang, X Huang, Z Liu, W Qin, C Wang Molecular oncology 14 (4), 896-913, 2020 | 166 | 2020 |
| The prognostic and clinicopathological roles of PD-L1 expression in colorectal cancer: a systematic review and meta-analysis Y Li, M He, Y Zhou, C Yang, S Wei, X Bian, O Christopher, L Xie Frontiers in pharmacology 10, 139, 2019 | 108 | 2019 |
| A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer C Yang, H Zhang, M Chen, S Wang, R Qian, L Zhang, X Huang, J Wang, ... Elife 11, e71880, 2022 | 95 | 2022 |
| Precision treatment in advanced hepatocellular carcinoma X Yang, C Yang, S Zhang, H Geng, AX Zhu, R Bernards, W Qin, J Fan, ... Cancer Cell 42 (2), 180-197, 2024 | 84 | 2024 |
| Risk of skin cancers in thiopurines‐treated and thiopurines‐untreated patients with inflammatory bowel disease: A systematic review and meta‐analysis SZ Huang, ZC Liu, WX Liao, JX Wei, XW Huang, C Yang, YH Xia, L Li, ... Journal of Gastroenterology and Hepatology 34 (3), 507-516, 2019 | 46 | 2019 |
| Exploring liver cancer biology through functional genetic screens C Wang, Y Cao, C Yang, R Bernards, W Qin Nature reviews Gastroenterology & hepatology 18 (10), 690-704, 2021 | 45 | 2021 |
| Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer X Huang, T Sun, J Wang, X Hong, H Chen, T Yan, C Zhou, D Sun, C Yang, ... Cancer Research 83 (14), 2358-2371, 2023 | 43 | 2023 |
| Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer Z Huang, Y Liu, C Yang, X Li, C Pan, J Rao, N Li, W Liao, L Lin BMC cancer 18, 1-9, 2018 | 32 | 2018 |
| Risk of lymphoma in patients with inflammatory bowel disease treated with anti-tumour necrosis factor alpha agents: a systematic review and meta-analysis C Yang, J Huang, X Huang, S Huang, J Cheng, W Liao, X Chen, X Wang, ... Journal of Crohn's and Colitis 12 (9), 1042-1052, 2018 | 30 | 2018 |
| Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer Y Guo, J Wang, B Benedict, C Yang, F van Gemert, X Ma, D Gao, H Wang, ... Genome Medicine 13, 1-15, 2021 | 29 | 2021 |
| Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy Y Li, C Yang, Z Liu, S Du, S Can, H Zhang, L Zhang, X Huang, Z Xiao, X Li, ... Molecular cancer 21, 1-16, 2022 | 23 | 2022 |
| The prognostic role of pretreatment thrombocytosis in gastric cancer: A systematic review and meta-analysis C Yang, H Jiang, S Huang, H Hong, X Huang, X Wang, W Liao, X Wang, ... Medicine 97 (31), e11763, 2018 | 22 | 2018 |
| CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1 B Miao, Z Hu, R Mezzadra, L Hoeijmakers, A Fauster, S Du, Z Yang, ... Cancer cell 41 (10), 1817-1828. e9, 2023 | 21 | 2023 |
| Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer C Yang, S Zhang, Z Cheng, Z Liu, L Zhang, K Jiang, H Geng, R Qian, ... Genome Medicine 14 (1), 142, 2022 | 18 | 2022 |
| Exploring subclass-specific therapeutic agents for hepatocellular carcinoma by informatics-guided drug screen C Yang, J Chen, Y Li, X Huang, Z Liu, J Wang, H Jiang, W Qin, Y Lv, ... Briefings in Bioinformatics 22 (4), bbaa295, 2021 | 18 | 2021 |
| Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2 S Wang, Y Zhou, R Yu, J Ling, B Li, C Yang, Z Cheng, R Qian, Z Lin, C Yu, ... JHEP Reports 5 (10), 100843, 2023 | 15 | 2023 |
| Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications X Huang, C Yang, J Wang, T Sun, H Xiong Aging (Albany NY) 12 (6), 4970, 2020 | 15 | 2020 |
